Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Esophageal Squamous Cell Carcinoma × Trastuzumab × 1 year × Clear all

Sponsor

Conditions

Breast Neoplasms 101 Stomach Neoplasms 17 HER2-positive Breast Cancer 13 Neoplasms 11 Neoplasm Metastasis 9 Colorectal Neoplasms 9 Esophageal Neoplasms 7 Triple Negative Breast Neoplasms 4 Meningeal Neoplasms 4 Colonic Neoplasms 4 Brain Neoplasms 4 Adenocarcinoma Of Esophagus 4 Salivary Gland Neoplasms 3 Rectal Neoplasms 3 Meningeal Carcinomatosis 3 Lymphoma, Non-Hodgkin 3 Lung Neoplasms 3 Gallbladder Neoplasms 3 Endometrial Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Biliary Tract Neoplasms 3 Anatomic Stage I Breast Cancer AJCC v8 3 Solid Tumors 2 Prostatic Neoplasms 2 Pathologic Complete Response 2 Ovarian Neoplasms 2 Multiple Myeloma 2 Inflammatory Breast Neoplasms 2 Hematologic Neoplasms 2 HER2-positive Gastric Cancer 2

Interventions

Cisplatin 22 Paclitaxel 17 pembrolizumab 14 Carboplatin 12 Radiotherapy 11 tislelizumab 9 Drug Therapy 9 Fluorouracil 8 toripalimab 7 Nivolumab 7 Irinotecan 7 Esophagectomy 6 Neoadjuvant Therapy 5 Docetaxel 5 Radiation 4 Oxaliplatin 4 Capecitabine 4 Albumin-Bound Paclitaxel 4 130-nm albumin-bound paclitaxel 4 nimotuzumab 3 lenvatinib 3 Taxes 3 Levoleucovorin 3 Leucovorin 3 spartalizumab 2 sintilimab 2 regorafenib 2 nedaplatin 2 durvalumab 2 apatinib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡